Skip to main content
Equibles

Rockefeller Capital Management L.P.

Position in PDSB — PDS Biotechnology Corp

CIK 1739439 NEW YORK, NY
Back to PDSB Full portfolio

Position in PDSB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,371
+$7,635 QoQ
Shares Held
27,664
0.0% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 52 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PDSB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $308,249,937 across 242 Biotechnology names. PDSB ranks #122 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 149,476 $74,249,211
2 JAZZ
Jazz Pharmaceuticals plc
 167,409 $40,340,545
3 ACAD
Acadia Pharmaceuticals Inc
 1,015,420 $25,690,124
4 BMRN
Biomarin Pharmaceutical Inc
 433,376 $24,797,774
5 PTCT
Ptc Therapeutics, Inc.
 302,393 $24,666,195
6 MDGL
Madrigal Pharmaceuticals, Inc.
 29,015 $15,579,603
7 REGN
Regeneron Pharmaceuticals, Inc.
 21,563 $13,445,391
8 CORT
Corcept Therapeutics Inc
 123,388 $10,728,585

All Filings in PDSB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,371 27,664
2026-03-31 $16,736 27,664
2025-12-31 $19,761 25,664
2025-09-30 $34,811 34,467
2022-12-31 $45,051 3,413
2022-03-31 $5,911 955
2021-12-31 $54,148 6,685
2021-09-30 $99,606 6,685
2021-06-30 $83,896 6,685